Robert T. Jones
Dana-Farber Cancer Institute · 62 works · 4,235 citations · h-index 16
Top works
- RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors
- Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
- Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
- Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas
- Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
- Oncogenic mutations in cervical cancer
- Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia
- Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5
- ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peridiagnosis Thromboembolic Events
- Sporadic hemangioblastomas are characterized by cryptic VHL inactivation
- Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
- Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy
- Abstract 3178: Can DNA from archived formalin-fixed paraffin embedded (FFPE) cancer tissues be used for somatic mutation analysis in next generation sequencing
- Pharmacogenomics
- Colorectal Cancers from Distinct Ancestral Populations Show Variations in BRAF Mutation Frequency
- TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer
- 2905 Genomic characterization of brain metastases and paired primary tumors reveals branched evolution and potential therapeutic targets
- Abstract 4286: Improved FFPE DNA extraction for next generation sequencing using adaptive focused acoustics technology
- Regulation of volume-regulated anion channels alters sensitivity to platinum chemotherapy
- NPEPPS Is a Druggable Driver of Platinum Resistance